United States, Rockville MD, Aug. 29, 2022 (GLOBE NEWSWIRE) -- As per the latest industry analysis by Fact.MR, a market research and competitive intelligence provider, the global sales of endometrial ablation devices is currently valued at over US$ 1 billion and is predicted to expand at a CAGR of 4% through 2027.
The endometrial lining of the uterus is removed or destroyed during an endometrial ablation operation to treat heavy monthly bleeding. The endometrial ablation devices market is anticipated to develop at a faster rate than average over the forecast period due to factors such as rising menorrhagia prevalence, increased awareness of endometrial ablation, and rising demand for minimally-invasive procedures.
Development of the market is aided by additional factors such as endometrial ablation's technological advancement and its advantages over surgical techniques. Endometrial ablation also has several benefits over other surgical procedures, including speedier recovery, less pain, minimum invasion, and shorter operation times.
Get Sample PDF of This Research Report with Detailed Table of Content:
https://www.factmr.com/connectus/sample?flag=S&rep_id=7654
These elements contribute to an increase in endometrial ablation demand globally. However, strict government rules for endometrial ablation device approval and endometrial ablation risks are anticipated to restrain market expansion to some extent.
Key Takeaways from Market Study
- Radiofrequency ablation equipment currently accounts for the largest market share among all the technologies and is projected to maintain its dominance over the coming years as well.
- Due to improvements in endometrial ablation technologies that do not require a lot of space and can therefore be employed in clinics, the clinics segment currently accounts for the most revenue generation.
- Due to its large population, rising demand for minimally-invasive treatments, expanding healthcare infrastructure, and growing awareness of endometrial ablation procedures, Asia Pacific offers profitable potential for market participants selling endometrial ablation equipment.
- Sales of endometrial ablation devices are expected to increase at a CAGR of 4% from 2022 to 2027.
Speak to Analyst:
https://www.factmr.com/connectus/sample?flag=AE&rep_id=7654
Segments of Endometrial Ablation Devices Industry Research
- By Product :
- Radiofrequency Endometrial Ablation
- Cryoablation
- Hydrothermal Ablation
- Thermal Balloon Ablation
- Hysteroscopy Devices
- By End User :
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Winning Strategy
The market is quite competitive because there are numerous domestic and international firms. Major businesses are using a variety of growth strategies to capture a substantial portion of the market, including new product development, product differentiation strategies, financing, etc.
- For instance, Cooper Surgical purchased AEGEA Medical and its MaraTM Water Vapor Ablation System in February 2021.
Competitive Landscape
A majority of manufacturers are concentrating on purchasing technologies created by rivals to expand their product line. Despite the market for endometrial ablation devices being consolidated, new competitors are entering it by releasing a variety of endometrial ablation products and accessories.
- For over US$ 350 million, Medtronic plc purchased Smith & Nephew's gynaecological division in 2016. Through this agreement, Medtronic acquired TRUCLEAR System, a crucial gynaecological product from Smith & Nephew.
- In 2019, following Aveta's FDA approval, ShangBay Capital LLC and Aethan Capital, Inc. organized a US$ 13 million equity funding round for Meditrina Inc. This illustrates the market for hysteroscopy systems' growth potential during the anticipated term.
Quick Buy – Endometrial Ablation Devices Market Research Report:
https://www.factmr.com/checkout/7654
Rising Cases of Endometriosis Driving Demand for Endometrial Ablation Devices
- The U.S. Department of Health and Human Services estimates that 11% of American women experience endometriosis, which causes inflammation when the tissue reacts to a woman's monthly menstrual cycle variations.
According to this data, the nation’s growing medical cases and sizable patient pool are driving market expansion.
Patient health outcomes and safety are of the utmost significance in the United States, and numerous initiatives have been formed to raise healthcare quality and cut costs. Another driver fueling the market's expansion in the United States is its high healthcare spending.
Check out more related studies published by Fact.MR Research:
Nerve Ablation Devices Market- Nerves are the vital part of the body, responsible for carrying signals from different parts of the body to the brain. The nerves carry electrical signals that act on actions such as pain and other movements of the body. The nerve ablation devices are used to treat patient by minimally invasive procedures, where a microelectrode is inserted inside the patient to heat the nerve tissue. According to the U.S. Department of Health and Human Services, NIH in recent year approx. 40 million adults are suffering from severe pain and approx. 25.3 million of adult’s population are suffering from pain every day for previous 3 months.
Atrial Fibrillation (AF) Ablation Market- Arterial fibrillation is a disease that creates irregular and rapid heart rate. Atrial fibrillation ablation is performed to treat the disease. The upper chambers of the heart beat irregularly and contract randomly at a very fast rate, out of coordination with the lower ventricles of the heart due to which the time decreases for the heart muscle relaxation. According to the Center for Disease Control and Prevention (CDC) an estimated of 2.7–6.1 million people are suffering from atrial fibrillation in the U.S. Moreover, almost 750,000 hospitalizations occur every year due to atrial fibrillation which is creating growth opportunities for the atrial fibrillation ablation market.
Neuro Ablation Devices Market - euro ablation devices are medical devices that are applied to iatrogenic Peripheral Nerve Injury (PNI). A peripheral nerve is composed of axon, myelin, endoneurium, fascicle, perineurium and epineurium. The individual myelinated axons and groups of unmyelinated axons are usually surrounded by the endoneurium. The growing prevalence of back pain, spinal injuries, neurological disorders and cancers is expected to be a major factor driving the neuro ablation devices market over the forecast period. For instance, more than 80% of the global population experiences lower back pain at-least once in their life. At any given time, lower back pain is prevalent in 4% to 33% of the population.
Cardiac Ablation Technologies Market - The cardiac ablation technologies market is forecast to reach US$ 4,919.35 Mn in 2022, up from US$ 4,427.89 Mn in 2021, representing a Y-o-Y increase of 11.1%.North America is expected to capture 37% share of the global cardiac ablation technologies market, as it consists of leading players-Johnson & Johnson, Abbott, and Boston Scientific Corporation.
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
Mahendra Singh
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
Email: sales@factmr.com
Tel: +1 (628) 251-158
